Versant Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
24
- Investments
-
493
- Portfolio
-
47
- Exits
-
230
Versant Ventures General Information
Company Description
Founded in 1999, Versant Ventures is a venture capital firm based in San Francisco, California. The firm seeks to invest in the healthcare sector. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
versantventures.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- One Sansome Street
- Suite 1650
- San Francisco, CA 94104
- United States
Versant Ventures Investments (493)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Jade Biosciences | 28-Apr-2025 | PIPE | Biotechnology | Generating Revenue | ||
| Helicore Biopharma | 16-Jan-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Light Horse Therapeutics | 09-Jan-2025 | Biotechnology | Startup | |||
| Antag Therapeutics | 04-Dec-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Borealis Biosciences | 27-Nov-2024 | Discovery Tools (Healthcare) | Startup | |||
| Saturnus Bio | 22-Nov-2024 | Pharmaceuticals | Startup | |||
| Pep2Tango Therapeutics | 20-Nov-2024 | Biotechnology | Pre-Clinical Trials | |||
| 858 Therapeutics | 26-Sep-2024 | Drug Discovery | Clinical Trials - General | |||
| Santa Ana Bio | 13-Jun-2024 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Bright Peak Therapeutics | 11-Jun-2024 | Later Stage VC | Drug Discovery | Pre-Clinical Trials |
Versant Ventures Exits (230)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Vector Biopharma | 07-Jul-2025 | Bankruptcy: Liquidation | |
| Halio | 20-Feb-2025 | ||
| Kate Therapeutics | 31-Oct-2024 | ||
| Jnana Therapeutics | 08-Oct-2024 | ||
| Monte Rosa Therapeutics | 16-May-2024 | ||
| Matterhorn Biosciences | 27-Apr-2024 | ||
| Contineum Therapeutics | 05-Apr-2024 | ||
| Q32 Bio | 25-Mar-2024 | ||
| LENZ Therapeutics | 21-Mar-2024 | Reverse Merger | |
| SanReno Therapeutics | 05-Jan-2024 | Merger/Acquisition |
Versant Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Versant Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Versant Ventures Co-Investors (149)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 8 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| Casdin Capital |
|
|
|||
| New Enterprise Associates |
|
|
|||
| OrbiMed |
|
|
Versant Ventures Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ridgeline Discovery | Basel, Switzerland | 2017 | |
| Highline Therapeutics | New York, NY | 2015 |
Versant Ventures FAQs
-
What is Versant Ventures?
Founded in 1999, Versant Ventures is a venture capital firm based in San Francisco, California.
-
When was Versant Ventures founded?
Versant Ventures was founded in 1999.
-
Where is Versant Ventures headquartered?
Versant Ventures is headquartered in San Francisco, CA.
-
What is Versant Ventures's total asset value?
Versant Ventures has around in total assets under management.
-
How many investments has Versant Ventures made?
Versant Ventures has made 493 investments.
-
What has Versant Ventures invested in?
Versant Ventures has made numerous investments in companies like Jade Biosciences, Helicore Biopharma, and Light Horse Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has Versant Ventures invested in recently?
Versant Ventures's latest investment was on 28-Apr-2025 in Jade Biosciences, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
